News – Page 2 – www.brainwork.md

12th September 2019

Smartphone-controlled device could revolutionise drug delivery in the brain

https://www.brainwork.md/content/uploads/2019/09/Brainwork-SmartphoneControlled.jpg 3450 2300 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 12th September 2019 24th September 2019

A novel brain implant that can deliver drugs and stimulate brain cells could lead to advanced treatments for Parkinson’s, Alzheimer’s, and other brain disorders, a new study reports. The research comes…

Peter Stevenson, PhD
0
0

30th July 2019

Chili proving a hot topic in cognitive decline

https://www.brainwork.md/content/uploads/2019/07/Brainwork-Chili.jpg 3150 2100 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 30th July 2019 30th July 2019

A large study across China has uncovered that eating spicy foods increases the risk of dementia, further calling into question the pertinent links between diet and cognitive function. The China Health and…

Peter Stevenson, PhD
0
0

10th July 2019

“Less is more” in medication-overuse headache

https://www.brainwork.md/content/uploads/2019/07/MPR585-Brainwork-EAN-V00-03-20190701_hero-banner.jpg 6668 2484 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 10th July 2019 15th July 2019

Monitoring, recognition and effective patient education are cornerstones in the diagnosis and prevention of medication-overuse headache (MOH), delegates heard at the 5th Annual Congress of the European Academy of Neurology…

Peter Stevenson, PhD
0
0

9th July 2019

Treating nature with NURTURE: Interim results of nusinersen for SMA

https://www.brainwork.md/content/uploads/2019/07/Brainwork-NURTURE.jpg 3473 2300 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 9th July 2019 9th July 2019

Promising results for a disease-modifying treatment for spinal muscular atrophy (SMA) were presented at the 5th Annual Congress of the European Academy of Neurology (EAN) in Oslo, Norway, last week.…

Mea Holm, PhD
0
0

9th July 2019

Natalizumab treatment associated with reduction of gliotic biomarkers in white matter

https://www.brainwork.md/content/uploads/2019/07/Brainwork-Natalizumab.jpg 3067 2300 Michael Furrer, PhD Michael Furrer, PhD https://secure.gravatar.com/avatar/47c43996bf9448b78126dd0c38021678?s=96&d=mm&r=g 9th July 2019 9th July 2019

New data on the effect of natalizumab treatment on neuronal and membrane integrity in lesional white matter were presented at the recent 5th Annual Congress of the European Academy of…

Michael Furrer, PhD
0
0

9th July 2019

Serum NfL levels shine a light on neuroaxonal damage and disease

https://www.brainwork.md/content/uploads/2019/07/Brainwork-NfL.jpg 4089 2300 Michael Furrer, PhD Michael Furrer, PhD https://secure.gravatar.com/avatar/47c43996bf9448b78126dd0c38021678?s=96&d=mm&r=g 9th July 2019 9th July 2019

The 5th Annual Congress of the European Academy of Neurology (EAN) in Oslo, Norway, featured an in-depth exploration of the role of neurofilament light chain (NfL) protein levels as a…

Michael Furrer, PhD
0
0

9th July 2019

Cellular power failures linked to Parkinsonism

https://www.brainwork.md/content/uploads/2019/07/Brainwork-Parkinsonism.jpg 3150 2100 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 9th July 2019 9th July 2019

Mounting evidence is linking neurodegenerative disorders, such as Parkinsonism and dementia, with mitochondrial dysfunction.1 At the 5th Annual Congress of the European Academy of Neurology (EAN) in Oslo, Norway, the…

Mea Holm, PhD
0
0

4th July 2019

8-year follow-up data of alemtuzumab presented

https://www.brainwork.md/content/uploads/2019/07/follow-up-data-of-alemtuzumab-presented-image.jpg 1920 1280 Michael Furrer, PhD Michael Furrer, PhD https://secure.gravatar.com/avatar/47c43996bf9448b78126dd0c38021678?s=96&d=mm&r=g 4th July 2019 9th July 2019

An update of the long-term efficacy and safety data of alemtuzumab in patients with relapsing-remitting MS was presented at the 5th Annual Congress of the European Academy of Neurology (EAN)…

Michael Furrer, PhD
0
0

1st July 2019

Thought-controlled prosthetic limbs could be in reach

https://www.brainwork.md/content/uploads/2019/07/Brainwork-ProstheticLimb.jpg 3446 2300 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 1st July 2019 15th July 2019

Improvements in the way in which neural activity is mapped could be an important step towards thought-controlled body augmentations such as prosthetic limbs, researchers at the Neural Prosthetics Translational Laboratory…

Peter Stevenson, PhD
0
0

20th June 2019

Machine-learning algorithm predicts psychosis from speech

https://www.brainwork.md/content/uploads/2019/06/Brainwork-MachineLearning.jpg 3150 2100 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 20th June 2019 19th June 2019

Algorithms designed to find hidden clues within everyday language can predict those at risk of developing psychosis, a new study reports. Using machine learning, researchers from the Department of Psychology…

Peter Stevenson, PhD
0
0